Neuronetics To Present Clinical Data at The American Psychiatric Association 2021 Annual Meeting
April 29, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., April 29, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Enhances TrakStar® Cloud Patient Data Management System to Maximize Physician Efficiencies
March 09, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., March 09, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Names Cory Anderson Vice President, Clinical Affairs and Medical Operations
March 03, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., March 03, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
NeuroStar® Advanced Therapy Outcomes Registry Clinical Data Published in Brain Stimulation Validates Depression Treatment Protocols
February 23, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Announces Strategic Leadership Promotions to Support Future Growth
February 11, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
NeuroStar® Advanced Therapy’s Depression Outcomes Registry Hits 10,000 Patient Milestone
January 19, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Announces the Amendment of Credit Facility with Solar Capital Partners
December 08, 2020 16:05 ET
|
Neuronetics
MALVERN, Pa., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics® Receives FDA Clearance for Three-Minute TouchStar™ Treatment Protocol
November 23, 2020 16:05 ET
|
Neuronetics
MALVERN, Pa., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Reports Third Quarter 2020 Financial and Operating Results
November 02, 2020 16:05 ET
|
Neuronetics
MALVERN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Journal of Affective Disorders Publishes Clinical Data Suggesting NeuroStar® Advanced Therapy as a First-line Treatment for Major Depressive Disorder
October 13, 2020 08:00 ET
|
Neuronetics
MALVERN, Pa., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...